Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.
about
Cryptococcus gattii infectionsDe novo GTP Biosynthesis Is Critical for Virulence of the Fungal Pathogen Cryptococcus neoformansDifferences in nitrogen metabolism between Cryptococcus neoformans and C. gattii, the two etiologic agents of cryptococcosisResistance of Asian Cryptococcus neoformans serotype A is confined to few microsatellite genotypesSpread ofCryptococcus gattiiinto Pacific Northwest Region of the United StatesMicrosatellite typing of clinical and environmental Cryptococcus neoformans var. grubii isolates from Cuba shows multiple genetic lineages.Real-time PCR assays for genotyping of Cryptococcus gattii in North AmericaIn vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Prevalence of cryptococcal meningitis among people living with human immunodeficiency virus/acquired immunodeficiency syndrome in a Tertiary Care Hospital, Southern Odisha, IndiaMatrix-assisted laser desorption ionization-time of flight mass spectrometry-based method for discrimination between molecular types of Cryptococcus neoformans and Cryptococcus gattiiMALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype.Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1.Cryptococcosis of lumbar vertebra in a patient with rheumatoid arthritis and scleroderma: case report and literature review.An update on Cryptococcus among HIV-infected patients.Geographically structured populations of Cryptococcus neoformans Variety grubii in Asia correlate with HIV status and show a clonal population structure.Treatment and outcomes among patients with Cryptococcus gattii infections in the United States Pacific Northwest.Galleria mellonella model identifies highly virulent strains among all major molecular types of Cryptococcus gattiiUnraveling unique structure and biosynthesis pathway of N-linked glycans in human fungal pathogen Cryptococcus neoformans by glycomics analysis.Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population.Recent Taxonomic Developments with Candida and Other Opportunistic Yeasts.Autochthonous and dormant Cryptococcus gattii infections in EuropeCryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.Comparison of biotyping methods as alternative identification tools to molecular typing of pathogenic Cryptococcus species in sub-Saharan Africa.Applying genetics and molecular biology to the study of the human pathogen Cryptococcus neoformansCryptococcus gattii: Emergence in Western North America: Exploitation of a Novel Ecological Niche.Cryptococcus gattii: An Emerging Cause of Fungal Disease in North America.Immunity to Cryptococcus neoformans and C. gattii during cryptococcosisImpact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.The yeast-phase virulence requirement for α-glucan synthase differs among Histoplasma capsulatum chemotypes.Disseminated Cryptococcal Disease in Non-HIV, Nontransplant PatientLow diversity Cryptococcus neoformans variety grubii multilocus sequence types from Thailand are consistent with an ancestral African origin.Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method.Azole resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the role of ERG11.Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States.Genotypic analysis of clinical and environmental Cryptococcus neoformans isolates from Brazil reveals the presence of VNB isolates and a correlation with biological factors.Genetic Factors and Genotype-Environment Interactions Contribute to Variation in Melanin Production in the Fungal Pathogen Cryptococcus neoformans.
P2860
Q27002687-EF3A03AA-B38B-4C3E-9394-3F23D11F25F6Q27674590-D2B91CAD-1B30-4918-B644-C0C3588F1DEAQ28481671-8F5EB206-E283-4888-9CB0-C0392D4E5EA8Q28731332-C80F2A2D-E0F1-4BDC-A1DA-9C8522412A95Q30048584-EF77809F-4F2C-4586-AEC9-7BA77F286BDAQ33531759-44A06D6E-66D0-476E-9731-5292746E8EA4Q33655285-437FA7B8-85FE-42B2-8F68-0457ABAA0A68Q33696932-BBB9CECF-3322-4F6C-8B6B-524B5BA0CE9FQ33894565-22A2B8F9-B07D-4184-AA87-D44D6E962995Q34002859-317588E3-2627-4E0C-93FE-E93B9C19DD67Q34264267-5C2D62B2-E18A-46CC-945A-701CAA46D694Q34292528-847D24D5-70EC-4D3D-BDCB-6B16E3E2E516Q34489508-C749AB00-BC37-4FCE-A8BF-41EB3B472809Q34596637-CAE273E5-2776-486C-81F5-F50D540CD385Q34621798-792B2560-9EB4-43DB-A13C-7AA63987CEEFQ34625655-88BDB7F8-87E8-4644-BDDD-B199382BF05AQ34982672-8A7C1F9C-02DB-4153-94D8-33FF3031EBEFQ35106377-8C47FB67-7B39-4271-AC84-1F015E44E8D2Q35227221-22643D8A-E09A-4760-8ADF-0A1EA332FFDCQ36003854-F1EA75EB-60B8-4F8A-8268-111FBBC67E9AQ36018713-B31DCAE0-1BD0-4535-848C-18B66CBFCD1AQ36022995-35648525-7FE0-4CC1-AE10-64522F28C544Q36225962-F6248CA8-2F9F-48F0-806B-2FE9BC0597CEQ36318438-DEB66C17-E66D-48D9-B078-C57787C03768Q36364064-A2E55998-D441-428F-93F8-DA9893B91488Q36600275-E3A2C82F-9DE2-4662-985A-1C0DBB8D65BBQ36727532-AC3C052F-A067-4426-BAD8-8969F25574D1Q37111315-D5AFEC03-95F1-4141-9B3D-72F371817107Q37201768-F4F503A5-69FC-45CF-99FA-A203797D053AQ38286732-E30C2017-6A69-4B7C-99B4-E7F706D8C212Q38467366-5D9180DF-3A16-41B6-B72C-C46C5C7C2F48Q39637666-4AAE4CB5-ABDA-415C-B24C-F8A3DDE9C465Q40412389-8EE055BB-8549-4C87-98EE-1F277F569435Q40797334-B4002878-8F92-4815-8A0D-3688B9DF538CQ41702288-6D2319FA-42CB-45CE-99F2-2C9F50D914C2Q42110028-D97571AE-215D-4B69-BC24-04B3B8FBEEE0Q42924504-537A2D38-91A0-44F5-86E8-3AE59A947D24Q52367214-B2E93176-798F-4B73-A8BE-E9FC3593819FQ55453749-F2A6C70A-0EF6-4B60-A46E-442FAC2541C0
P2860
Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.
@en
Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.
@nl
type
label
Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.
@en
Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.
@nl
prefLabel
Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.
@en
Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.
@nl
P1476
Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex.
@en
P2093
Ferry Hagen
Marjan Bovers
P577
2008-03-01T00:00:00Z